|
HY-10220-1mg
|
MedChemexpress LLC
|
SF1126 [CAS 936487-67-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10220-10mg
|
MedChemexpress LLC
|
SF1126 [CAS 936487-67-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10220-100mg
|
MedChemexpress LLC
|
SF1126 [CAS 936487-67-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10220-25mg
|
MedChemexpress LLC
|
SF1126 [CAS 936487-67-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10220-5mg
|
MedChemexpress LLC
|
SF1126 [CAS 936487-67-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10220-50mg
|
MedChemexpress LLC
|
SF1126 [CAS 936487-67-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-106244-1mg
|
MedChemexpress LLC
|
DOTATATE [CAS 177943-88-3]
|
|
Cancer-programmed cell death
|
|
|
HY-106244-10mg
|
MedChemexpress LLC
|
DOTATATE [CAS 177943-88-3]
|
|
Cancer-programmed cell death
|
|
|
HY-106244-5mg
|
MedChemexpress LLC
|
DOTATATE [CAS 177943-88-3]
|
|
Cancer-programmed cell death
|
|
|
HY-106244A-1mg
|
MedChemexpress LLC
|
DOTATATE (acetate) [CAS 177943-89-4]
|
|
Cancer-programmed cell death
|
|
|
HY-106244A-10mg
|
MedChemexpress LLC
|
DOTATATE (acetate) [CAS 177943-89-4]
|
|
Cancer-programmed cell death
|
|
|
HY-106244A-100mg
|
MedChemexpress LLC
|
DOTATATE (acetate) [CAS 177943-89-4]
|
|
Cancer-programmed cell death
|
|
|
HY-106244A-25mg
|
MedChemexpress LLC
|
DOTATATE (acetate) [CAS 177943-89-4]
|
|
Cancer-programmed cell death
|
|
|
HY-106244A-5mg
|
MedChemexpress LLC
|
DOTATATE (acetate) [CAS 177943-89-4]
|
|
Cancer-programmed cell death
|
|
|
HY-106244A-50mg
|
MedChemexpress LLC
|
DOTATATE (acetate) [CAS 177943-89-4]
|
|
Cancer-programmed cell death
|
|
|
HY-107869-100mg
|
MedChemexpress LLC
|
Isoindigo [CAS 476-34-6]
|
|
|
|
|
HY-107869-50mg
|
MedChemexpress LLC
|
Isoindigo [CAS 476-34-6]
|
|
|
|
|
HY-111895A-10mg
|
MedChemexpress LLC
|
Macropa-NH2 (hydrochloride) [CAS 2443966-86-5]
|
|
Cancer-programmed cell death
|
|
|
HY-111895A-100mg
|
MedChemexpress LLC
|
Macropa-NH2 (hydrochloride) [CAS 2443966-86-5]
|
|
Cancer-programmed cell death
|
|
|
HY-111895A-25mg
|
MedChemexpress LLC
|
Macropa-NH2 (hydrochloride) [CAS 2443966-86-5]
|
|
Cancer-programmed cell death
|
|
|
HY-111895A-5mg
|
MedChemexpress LLC
|
Macropa-NH2 (hydrochloride) [CAS 2443966-86-5]
|
|
Cancer-programmed cell death
|
|
|
HY-111895A-50mg
|
MedChemexpress LLC
|
Macropa-NH2 (hydrochloride) [CAS 2443966-86-5]
|
|
Cancer-programmed cell death
|
|
|
HY-111895B-10mg
|
MedChemexpress LLC
|
Macropa-NH2 (TFA) [CAS 2705054-08-4]
|
|
|
|
|
HY-111895B-100mg
|
MedChemexpress LLC
|
Macropa-NH2 (TFA) [CAS 2705054-08-4]
|
|
|
|
|
HY-111895B-25mg
|
MedChemexpress LLC
|
Macropa-NH2 (TFA) [CAS 2705054-08-4]
|
|
|
|
